Showing 5661-5680 of 8668 for: Cochrane Systematic Reviews Back
- Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
Cochrane Systematic Reviews, 25-Nov-2016
Breathlessness is a cardinal symptom of chronic obstructive pulmonary disease (COPD). Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxaemia at rest. The efficacy of oxygen therapy for breathles
- Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a rapid review
Cochrane Systematic Reviews, 1-Sep-2020
Supplemental oxygen is frequently administered to patients with acute respiratory distress syndrome (ARDS), including ARDS secondary to viral illness such as coronavirus disease 19 (COVID-19). An up-to-date understanding of how best to target this therapy
- Oxygen therapy during exercise training in chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 11-Jun-2009
Exercise training within the context of pulmonary rehabilitation improves outcomes of exercise capacity, dyspnea and health-related quality of life in individuals with chronic obstructive pulmonary disease (COPD). Supplemental oxygen in comparison to plac
- Oxygen therapy for acute myocardial infarction
Cochrane Systematic Reviews, 19-Dec-2016
Oxygen (O2) is widely used in people with acute myocardial infarction (AMI). Previous systematic reviews concluded that there was insufficient evidence to know whether oxygen reduced, increased or had no effect on heart ischaemia or infarct size. Our firs
- Oxygen therapy for cystic fibrosis
Cochrane Systematic Reviews, 25-Jul-2013
The most serious complications of cystic fibrosis (CF) relate to respiratory insufficiency. Oxygen supplementation therapy has long been a standard of care for individuals with chronic lung diseases associated with hypoxemia. Physicians commonly prescribe
- Oxygen therapy for dyspnoea in adults
Cochrane Systematic Reviews, 20-Nov-2013
Dyspnoea, or distressing breathing, is often a severe subjective symptom in terminal illness and may be difficult to control. Oxygen therapy is currently one of the interventions used to treat it. This review aimed to identify all randomised controlled st
- Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age
Cochrane Systematic Reviews, 10-Dec-2014
Treatment for lower respiratory tract infections (LRTIs) includes administering complementary oxygen. The effectiveness of oxygen therapy and of different delivery methods remains uncertain.
- Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 14-Jan-2020
Chronic obstructive pulmonary disease (COPD) is a global leading cause of morbidity and mortality, characterised by acute deterioration in symptoms. During these exacerbations, people are prone to developing alveolar hypoventilation, which may be partly c
- Oxytocin antagonists for assisted reproduction
Cochrane Systematic Reviews, 1-Sep-2021
Embryo transfer (ET) is a crucial step of in vitro fertilisation (IVF) treatment, and involves placing the embryo(s) in the woman’s uterus. There is a negative association between endometrial wave-like activity (contractile activities) at the time of ET a
- Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries
Cochrane Systematic Reviews, 11-Jul-2013
The rate of operative deliveries (both caesarean sections, vacuum extractions and forceps), continues to rise throughout the world. These are associated with significant maternal and neonatal morbidity. The most common reasons for operative births in null
- Oxytocin for prelabour rupture of membranes at or near term
Cochrane Systematic Reviews, 6-Nov-2008
Induction of labour after prelabour rupture of membranes may reduce the risk of neonatal infection.
- Oxytocin for preventing postpartum haemorrhage (PPH) in non‐facility birth settings
Cochrane Systematic Reviews, 14-Apr-2016
Postpartum haemorrhage (PPH) is the single leading cause of maternal mortality worldwide. Most of the deaths associated with PPH occur in resource-poor settings where effective methods of prevention and treatment - such as oxytocin - are not accessible be
- Oxytocin receptor antagonists for inhibiting preterm labour
Cochrane Systematic Reviews, 6-Jun-2014
Preterm birth, defined as birth between 20 and 36 completed weeks, is a major contributor to perinatal morbidity and mortality globally. Oxytocin receptor antagonists (ORA), such as atosiban, have been specially developed for the treatment of preterm labo
- Oxytocin versus no treatment or delayed treatment for slow progress in the first stage of spontaneous labour
Cochrane Systematic Reviews, 23-Jun-2013
Slow progress in the first stage of spontaneous labour is associated with an increased caesarean section rate and fetal and maternal morbidity. Oxytocin has long been advocated as a treatment for slow progress in labour but it is unclear to what extent it
- Ozone therapy for the treatment of dental caries
Cochrane Systematic Reviews, 7-Feb-2019
Dental caries is a bacterially mediated disease characterised by demineralisation of the tooth surface, which may lead to cavitation, discomfort, pain and eventual tooth loss. Ozone is toxic to certain bacteria in vitro and it has been suggested that deli
- Ozone therapy for treating foot ulcers in people with diabetes
Cochrane Systematic Reviews, 27-Oct-2015
It has been reported that ozone therapy might be helpful in treating foot ulcers in people with diabetes mellitus (DM).
- Pacing for drug‐refractory or drug‐intolerant hypertrophic cardiomyopathy
Cochrane Systematic Reviews, 16-May-2012
Hypertrophic cardiomyopathy (HCM) is a genetic disease with an autosomal-dominant inheritance for which negative inotropes are the most widely used initial therapies. Observational studies and small randomised trials have suggested symptomatic and functio
- Package of care for active management in labour for reducing caesarean section rates in low‐risk women
Cochrane Systematic Reviews, 16-Sep-2013
Approximately 15% of women have caesarean sections (CS) and while the rate varies, the number is increasing in many countries. This is of concern because higher CS rates do not confer additional health gain but may adversely affect maternal health and hav
- Padma 28 for intermittent claudication
Cochrane Systematic Reviews, 29-Mar-2016
Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease that develops in a limb during exercise and is relieved with rest. Most drug treatments of IC have a limited effect in improving walking distance. Padma 28, a Tibetan herb
- Paediatric formulations of artemisinin‐based combination therapies for treating uncomplicated malaria in children
Cochrane Systematic Reviews, 8-Dec-2020
In endemic malarial areas, young children have high levels of malaria morbidity and mortality. The World Health Organization recommends oral artemisinin-based combination therapy (ACT) for treating uncomplicated malaria. Paediatric formulations of ACT hav